<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-2993346515708552092</id><updated>2012-02-02T09:00:04.302-03:00</updated><category term='mal-formações'/><category term='child'/><category term='cancer'/><category term='erlotinib'/><category term='SIDA'/><category term='dermatite'/><category term='radiation'/><category term='ScienceNOW'/><category term='pediatria'/><category term='obesidade'/><category term='tacerva'/><category term='PET/CT'/><category term='immunology'/><category term='risco'/><category term='monoclonais'/><category term='alergia'/><category term='imunossupressores'/><category term='tumores pediátricos'/><category term='tumores cerebrais'/><category term='imagem'/><category term='macrophage activation syndrome'/><category term='antifúngicos'/><category term='carne vermelha'/><category term='anti-histamínico'/><category term='insulina'/><category term='suplementos'/><category term='gordos'/><category term='sulfa'/><category term='diabetes'/><category term='lepra'/><category term='mudança'/><category term='estilo de vida'/><category term='exercícios'/><category term='doenças cardíacas'/><category term='genetics'/><category term='avastin'/><category term='brain tumor'/><category term='bevacizumab'/><category term='dor'/><category term='tireóide'/><category term='dislipidemias'/><category term='modelos'/><category term='antianêmicos'/><category term='hemangiomas'/><category term='imunoterapia'/><category term='selênio'/><category term='próstata'/><category term='asthma'/><category term='pharmacological treatment'/><category term='inibidores de ECA'/><category term='propranolol'/><category term='inibidores tirosina-quinase'/><category term='vitaminas'/><category term='neuroblastoma'/><category term='DPOC'/><category term='ômega 3'/><category term='ciência'/><category term='alto custo'/><category term='dieta'/><category term='fibromialgia'/><category term='morte'/><category term='antivirais'/><category term='anti-eméticos'/><category term='novas drogas'/><category term='chronic fatigue syndrome'/><category term='seguimento'/><category term='hemophagocytic lymphohistiocytosis'/><category term='publicações'/><category term='asma'/><category term='pressão arterial'/><category term='anti-helmínticos'/><category term='infecção urinária'/><category term='FMJ'/><category term='novos tratamentos'/><category term='radioterapia'/><category term='rapamycin'/><category term='analgésicos'/><category term='fatores de crescimento'/><category term='targeted therapy'/><category term='quimioterapia'/><category term='disautonomia'/><category term='esteróides'/><category term='aulas'/><category term='pediatric tumors'/><category term='flu'/><category term='resposta'/><category term='osteoporose'/><category term='anticâncer'/><category term='ambiente'/><category term='vaccine'/><category term='temozolamida'/><category term='CT scans'/><category term='horário'/><category term='science'/><category term='tuberculose'/><category term='neurology'/><category term='estatinas'/><category term='pediatrics'/><category term='vitamina E'/><category term='anticoagulantes'/><category term='vacina'/><category term='pharmacology'/><category term='eczema'/><category term='serotonina'/><category term='farmacologia'/><category term='eritropoietina'/><category term='glioblastoma'/><category term='pubmed'/><category term='darbopoietina'/><category term='antiprotozoários'/><category term='doença renal'/><category term='magrinhas'/><category term='atopia'/><category term='recidiva'/><category term='temozolomide'/><category term='Lectures'/><category term='ESA'/><category term='antiangiogênico'/><category term='fitness'/><category term='mortalidade'/><category term='prevenção'/><category term='alquilantes'/><title type='text'>Pharmakon Pediatrics</title><subtitle type='html'>Câncer, drogas, imagens, farmacologia, oncologia e hematologia!</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://pharmak.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default?start-index=101&amp;max-results=100'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>187</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1056883543385702748</id><published>2012-02-02T00:43:00.000-03:00</published><updated>2012-02-02T00:55:11.823-03:00</updated><title type='text'>Novo tratamento para linfangiomas da infância</title><summary type='text'>Malformações linfáticas, também conhecidas como linfangiomas, são anomalias vasculares congênitas incomuns, representando muitas vezes um desafio terapêutico. Seu tratamento é cirúrgico, via de regra, mas muitas vezes elas são difíceis, quando não impossíveis, de ressecar completamente. Outras estratégias envolvem a injeção de substâncias capazes de causar dano celular ou inflamação dentro dos </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1056883543385702748'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1056883543385702748'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2012/02/novo-tratamento-para-linfangiomas-da.html' title='Novo tratamento para linfangiomas da infância'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-5452828220815843675</id><published>2012-02-02T00:06:00.000-03:00</published><updated>2012-02-02T00:06:03.260-03:00</updated><title type='text'>For Its New Science Minister Brazil Picks ... A Scientist - via ScienceInsider</title><summary type='text'>SÃO PAULO, BRAZIL—Brazil has announced that Marco Antônio Raupp, currently president of the Brazilian Space Agency, will become the new minister of science, technology and innovation on 24 January. Unlike the man he will replace, 
Aloizio Mercadante, a leading figure in the Worker's Party with little background in science, Raupp, 73, has more than 40 years of experience in the field. His </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5452828220815843675'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5452828220815843675'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2012/02/for-its-new-science-minister-brazil.html' title='For Its New Science Minister Brazil Picks ... A Scientist - via ScienceInsider'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2137334643687469982</id><published>2012-02-01T23:52:00.000-03:00</published><updated>2012-02-01T23:52:44.494-03:00</updated><title type='text'>Una dieta rica en antioxidantes para la prevención del accidente cerebrovascular - via Revista de Neurología</title><summary type='text'>
El
 uso de una dieta rica en antioxidantes puede reducir significativamente
 el riesgo de padecer un accidente cerebrovascular en mujeres.

 

Un estudio prospectivo, publicado en la revista Stroke,
 encontró que las mujeres sin antecedentes de enfermedades 
cardiovasculares que consumían una mayor cantidad de antioxidantes en 
alimentos como las frutas, verduras, té, cereales integrales y </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2137334643687469982'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2137334643687469982'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2012/02/una-dieta-rica-en-antioxidantes-para-la.html' title='Una dieta rica en antioxidantes para la prevención del accidente cerebrovascular - via Revista de Neurología'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3130846523056732541</id><published>2012-02-01T23:46:00.003-03:00</published><updated>2012-02-01T23:46:58.565-03:00</updated><title type='text'>El pescado, café y alcohol pueden retrasar la progresión de la esclerosis múltiple - via Revista de Neurología</title><summary type='text'>El consumo regular de pescado, alcohol y café puede ayudar a retrasar la aparición y progresión de la enfermedad en pacientes con esclerosis múltiple de recaídas múltiples (EM). Sin embargo, el consumo de estos alimentos no parece afectar al desarrollo de la enfermedad en pacientes con EM de inicio progresivo.

El estudio, publicado en la revista European Journal of Neurology incluyó datos de </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3130846523056732541'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3130846523056732541'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2012/02/el-pescado-cafe-y-alcohol-pueden.html' title='El pescado, café y alcohol pueden retrasar la progresión de la esclerosis múltiple - via Revista de Neurología'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1928839158361785399</id><published>2011-12-06T17:05:00.000-03:00</published><updated>2011-12-06T17:44:22.358-03:00</updated><title type='text'>Brazil in the Top 20 Countries in Scientific Research - ScienceWatch.com - Thomson Reuters</title><summary type='text'>According to a new update from                     Essential Science IndicatorsSM, a publication of         Thomson         Reuters, the ScienceWatch.com blog Webmaster Spyder Schafer presents the 10th            annual "Top 20" listings of countries which achieved         particular distinction based on their papers published in indexed journals from January 2001 through August 31, 2011. Out of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1928839158361785399'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1928839158361785399'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/12/brazil-in-top-20-countries-in.html' title='Brazil in the Top 20 Countries in Scientific Research - ScienceWatch.com - Thomson Reuters'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-5544444034286385040</id><published>2011-12-03T15:10:00.001-03:00</published><updated>2011-12-18T22:56:04.224-03:00</updated><title type='text'>Fraude na ciência 3 - o caso do Americano que Errou</title><summary type='text'>Um dos principais defensores da hipótese de que a moralidade é inata, 
tendo evoluído naturalmente nos ancestrais do homem, está sendo acusado 
de... fraude.

Marc Hauser, biólogo da Universidade Harvard, teria falsificado dados de
 experimentos, afirmam antigos subordinados do pesquisador.

Procurados pela Folha, tanto Hauser quanto a universidade se recusaram a
 falar. Em declaração oficial, </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5544444034286385040'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5544444034286385040'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/12/fraude-na-ciencia-3-o-americano-que.html' title='Fraude na ciência 3 - o caso do Americano que Errou'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1302411052866976745</id><published>2011-12-03T13:59:00.001-03:00</published><updated>2011-12-03T14:13:49.671-03:00</updated><title type='text'>Fraude na ciência 2 - o caso do Brasileiro Inconfesso</title><summary type='text'>Uma investigação internacional apontou fraude em 11 artigos 
científicos de um respeitado professor titular de química da Unicamp 
(Universidade Estadual de Campinas).

Tudo indica que se trata da denúncia mais séria de má conduta 
científica da história da ciência brasileira, apesar da escassez de 
levantamentos sobre o tema. Em geral, os casos envolvem plágio, e não 
invenção de resultados.

Os</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1302411052866976745'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1302411052866976745'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/12/fraude-na-ciencia-2-o-caso-do.html' title='Fraude na ciência 2 - o caso do Brasileiro Inconfesso'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7729661572671528419</id><published>2011-12-03T13:40:00.001-03:00</published><updated>2011-12-03T13:58:08.385-03:00</updated><title type='text'>Fraude na ciência 1 - o caso do Holandês Simulador</title><summary type='text'>
Acadêmicos da Holanda mostraram surpresa no mês de novembro ao 
constatar que um de seus mais prestigiados psicólogos sociais, Diederik 
Stapel, inventava grande parte dos dados que eram divulgados em seus 
artigos, que, inclusive, chegaram a ser publicados pela revista 
“Science”.


Embora a suspeita da fraude já tenha sido confirmada em 
setembro, quando o psicólogo foi impedido de exercer </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7729661572671528419'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7729661572671528419'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/12/fraude-na-ciencia-1-o-caso-do-holandes.html' title='Fraude na ciência 1 - o caso do Holandês Simulador'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-9127414341091777973</id><published>2011-11-24T20:58:00.000-03:00</published><updated>2011-11-24T20:58:58.613-03:00</updated><title type='text'>Media Education - from AAP</title><summary type='text'>Media Education: The American Academy of Pediatrics recognizes that exposure to mass media (eg, television, movies, video and computer games, the Internet, music lyrics and videos, newspapers, magazines, books, advertising) presents health risks for children and adolescents but can provide benefits as well. Media education has the potential to reduce the harmful effects of media and accentuate </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9127414341091777973'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9127414341091777973'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/media-education-from-aap.html' title='Media Education - from AAP'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-5484391952098958437</id><published>2011-11-24T20:50:00.000-03:00</published><updated>2011-11-24T20:50:28.345-03:00</updated><title type='text'>New UK clinical trial for relapsed neuroblastoma planned - via NB Globe - Neuroblastoma News</title><summary type='text'>New UK clinical trial for relapsed neuroblastoma planned: LONDON — November 7, 2011 — A new clinical trial testing 177Lutetium-DOTATATE (LuDO) for relapsed neuroblastoma is due to start in the UK next year. The UK is the first country to plan a clinical trial for this new molecular radiotherapy treatment for treating relapsed high-risk neuroblastoma, although it is already used to treat rare </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5484391952098958437'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5484391952098958437'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/new-uk-clinical-trial-for-relapsed.html' title='New UK clinical trial for relapsed neuroblastoma planned - via NB Globe - Neuroblastoma News'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-5994766559733705493</id><published>2011-11-23T14:14:00.001-03:00</published><updated>2011-11-23T14:35:31.959-03:00</updated><title type='text'>Programa do II Encontro Interdisciplinar de Assistência ao Paciente Oncológico</title><summary type='text'>O II Encontro Interdisciplinar de Assistência ao paciente Oncológico será realizado na Escola de Saúde Pública do Ceará (Av. Antonio Justa, 3161 - Meireles, Fortaleza-CE - Cep 60165-090 Fone: (85) 3101.1398 - Fax (85) 3101.1423) sob organização do Centro de Estudos Dr. Geraldo Barros de Oliveira, do Centro Regional Integrado de Oncologia - CRIO. 
Maiores informações, entrar em contato no endereço</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5994766559733705493'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5994766559733705493'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/programa-do-ii-encontro.html' title='Programa do II Encontro Interdisciplinar de Assistência ao Paciente Oncológico'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/-_evhn-dcptE/Ts0pyiStFNI/AAAAAAAABqk/HuyMESNr6KQ/s72-c/Programac%25CC%25A7a%25CC%2583o.docx.png' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4846425745591580322</id><published>2011-11-19T08:55:00.000-03:00</published><updated>2011-11-22T21:24:23.148-03:00</updated><title type='text'>What's new for 'fibromyalgia' in PubMed</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology 
Sender's message: Search: fibromyalgia 
Sent on Saturday, 2011 Nov 19
Search fibromyalgia 




PubMed Results





1.Relationship between body mass index,  fat mass and lean mass with SF-36 quality of life scores in a group of fibromyalgia patients.
Arranz L,  Canela MA,  Rafecas M.
Rheumatol Int. 2011 </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4846425745591580322'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4846425745591580322'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/whats-new-for-fibromyalgia-in-pubmed.html' title='What&apos;s new for &apos;fibromyalgia&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4898820472689678449</id><published>2011-11-17T15:03:00.000-03:00</published><updated>2011-11-17T15:54:12.538-03:00</updated><title type='text'>Aparelho consegue medir níveis de glicose em lágrima</title><summary type='text'>
Um estudo da Universidade de  Michigan, nos EUA, deu um passo importante para livrar diabéticos do  ritual incômodo de picar o dedo várias vezes por dia para medir os  níveis de glicose no sangue. A alternativa: lágrimas.
Ocorre que, segundo a equipe liderada por Mark Meyerhoff, o fluido das  lágrimas -que não aparece apenas quando as pessoas choram, mas está  presente com frequência como </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4898820472689678449'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4898820472689678449'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/aparelho-consegue-medir-niveis-de.html' title='Aparelho consegue medir níveis de glicose em lágrima'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-959823099370239617</id><published>2011-11-17T14:54:00.000-03:00</published><updated>2011-11-17T14:59:25.741-03:00</updated><title type='text'>Anvisa proíbe alimentos e bebidas à base de aloe vera</title><summary type='text'>A Agência Nacional de Vigilância Sanitária (Anvisa) proibiu a venda,  fabricação e importação de alimentos e bebidas à base de aloe vera. De  acordo com o órgão, não há comprovação da segurança do uso do componente  e nem registro para esse fim. A restrição foi publicada nesta  segunda-feira, no Diário Oficial da União.

A aloe vera é uma planta conhecida popularmente como babosa. É usada  </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/959823099370239617'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/959823099370239617'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/anvisa-proibe-alimentos-e-bebidas-base.html' title='Anvisa proíbe alimentos e bebidas à base de aloe vera'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-546116226776266136</id><published>2011-11-17T14:47:00.000-03:00</published><updated>2011-11-17T14:51:39.745-03:00</updated><title type='text'>Desenvolvimento pioneiro de nova droga bloqueadora da AKT</title><summary type='text'>A ArQule e a Daiichi Sankyo anunciaram esta quinta-feira a assinatura de  um contrato de licença para o desenvolvimento de um novo inibidor da AKT  chamado ARQ 092, o primeiro composto a surgir a partir do acordo que as  empresas assinaram em Novembro de 2008 “para colaborar na investigação  utilizando o AKIP ™ (ArQule Kinase Inhibitor Platform) para gerar novos,  seletivos e potentes inibidores </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/546116226776266136'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/546116226776266136'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/desenvolvimento-pioneiro-de-nova-droga.html' title='Desenvolvimento pioneiro de nova droga bloqueadora da AKT'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/-Iysb7InBYAc/TsVI58vVcoI/AAAAAAAABqU/Y-XHPBaL95k/s72-c/800px-Signal_transduction_v1.png' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1124413102904465547</id><published>2011-11-17T14:36:00.000-03:00</published><updated>2011-11-17T14:36:09.653-03:00</updated><title type='text'>O Fim das Células-Tronco Embrionárias?</title><summary type='text'>O teste clínico mais aguardado das últimas décadas está terminando de  forma inglória. A empresa americana Geron, primeira a empregar  células-tronco embrionárias em humanos, avisou que não vai mais  trabalhar nessa área.A Geron recebeu permissão do governo americano para injetar as células  na medula espinhal de cerca de dez pessoas com lesões recentes na área,  que as deixaram paralisadas -</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1124413102904465547'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1124413102904465547'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/o-fim-das-celulas-tronco-embrionarias.html' title='O Fim das Células-Tronco Embrionárias?'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1948982467769656362</id><published>2011-11-12T08:50:00.000-03:00</published><updated>2011-11-22T21:28:02.263-03:00</updated><title type='text'>What's new for 'cancer' in PubMed</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology Sender's message:  
Sent on Saturday, 2011 Nov 12
Search cancer 




PubMed Results



1.Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.
Weller M,  Gorlia T,  Cairncross JG,  van den Bent MJ,  Mason W,  Belanger K,  Brandes AA,  Bogdahn U,  Macdonald DR,  </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1948982467769656362'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1948982467769656362'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/11/whats-new-for-cancer-in-pubmed.html' title='What&apos;s new for &apos;cancer&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8915044658739236542</id><published>2011-10-26T18:54:00.001-03:00</published><updated>2011-11-10T09:06:38.993-03:00</updated><title type='text'>Riscos do uso de corticóide em recém-nascidos pré-termo</title><summary type='text'>
O número de crianças prematuras que nascem cada vez mais cedo e sobrevivem cada vez mais cresce dia a dia no mundo todo. Mesmo entre nós, no Brasil e, em particular, no estado do Ceará onde este comentarista reside, torna-se flagrante o impacto da tecnologia na sobrevivência  dos neonatos prematuros. No entanto, um número significante de crianças adquire problemas e sequelas, entre elas </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8915044658739236542'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8915044658739236542'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/riscos-do-uso-de-corticoide-em-recem.html' title='Riscos do uso de corticóide em recém-nascidos pré-termo'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-150844182093857761</id><published>2011-10-26T16:42:00.000-03:00</published><updated>2011-10-26T16:42:26.426-03:00</updated><title type='text'>Inmigración y cefaleas - via Revista de Neurología</title><summary type='text'>             La  población inmigrante (PI) es cada vez más común en la práctica clínica  habitual, y constituye un nuevo modelo poblacional, con quejas y  problemas altamente relacionados con la precariedad de su situación  laboral y social. Representan el 13,6% de las primeras visitas de  cefalea, y aunque sus diagnósticos son similares a los de la población  autóctona, existen diferencias en la</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/150844182093857761'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/150844182093857761'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/inmigracion-y-cefaleas-via-revista-de.html' title='Inmigración y cefaleas - via Revista de Neurología'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-733930428733494721</id><published>2011-10-23T13:02:00.002-03:00</published><updated>2011-10-23T13:02:16.493-03:00</updated><title type='text'>Efecto antidepresivo de la cafeína - via Revista de Neurología</title><summary type='text'>Las mujeres que toman más de cuatro tazas de café al día parecen tener un riesgo menor de sufrir una depresión que aquéllas que no toman café o solo beben una taza al día. Estos resultados aparecen publicados en la revista Archives of Internal Medicine.
Los investigadores siguieron a casi 51.000 mujeres con una edad promedio de 63 años, ninguna de las cuales tenía depresión ni tomaba </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/733930428733494721'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/733930428733494721'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/efecto-antidepresivo-de-la-cafeina-via.html' title='Efecto antidepresivo de la cafeína - via Revista de Neurología'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3895085829002573233</id><published>2011-10-23T12:59:00.000-03:00</published><updated>2011-10-23T12:59:36.099-03:00</updated><title type='text'>Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trial - Schrey - 2011 - Pediatric Blood &amp; Cancer - Wiley Online Library</title><summary type='text'>Recently published in Pediatric Blood and Cancer:The german ALL-BFM2000 trial reported on the relation between asparaginase activity monitoring in children during the treatment for acute leukemia.Asparaginase (ASNase) has been a core element in the treatment of acute  lymphoblastic leukemia (ALL) in children and adults over the last  decades. It reduces the exogenous supply of asparagine (ASN) by</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3895085829002573233'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3895085829002573233'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/five-year-single-center-study-of.html' title='Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trial - Schrey - 2011 - Pediatric Blood &amp; Cancer - Wiley Online Library'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-360059813653461801</id><published>2011-10-23T12:05:00.000-03:00</published><updated>2011-10-23T13:00:28.675-03:00</updated><title type='text'>Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents - Mora - 2011 - Pediatric Blood &amp; Cancer - Wiley Online Library</title><summary type='text'>Recently published in Pediatric Blood and Cancer:

Ewing sarcoma treatment is highly succesfull in non-metastatic patients, but the high-dose chemotherapy poses a significant risk of secondary leukemia. A group from Hospital Sant Joan de Déu, Barcelona, Spain has published a small phase II single-arm non-randomized study reporting good results with a less toxic, modified chemotherapy protocol. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/360059813653461801'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/360059813653461801'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/treatment-of-ewing-sarcoma-family-of.html' title='Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents - Mora - 2011 - Pediatric Blood &amp; Cancer - Wiley Online Library'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1721422458777912482</id><published>2011-10-20T13:07:00.001-03:00</published><updated>2011-10-20T13:07:13.608-03:00</updated><title type='text'>Primeiros Resultados do Tratamento de Hemangiomas com Propranolol no Ceará</title><summary type='text'>Hoje, na edição 2011 dos Encontros Universitários da Universidade Federal do Ceará, foi apresentado o poster "Tratamento com Propranolol em Crianças com Hemangioma", da aluna de graduação do Curso de Farmácia Juliana Costa Albuquerque, orientada pela professora Juvenia Bezerra Fontenele, da Farmácia da UFC. Este trabalho mostra resultados de uma avaliação retrospectiva coordenada por mim, dos </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1721422458777912482'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1721422458777912482'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/primeiros-resultados-do-tratamento-de.html' title='Primeiros Resultados do Tratamento de Hemangiomas com Propranolol no Ceará'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/-GpMyDbYtnJY/TqBG9DdmzCI/AAAAAAAABp8/DbHhq4u8YS4/s72-c/Grafico_hemangio.png' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4444474819323888775</id><published>2011-10-19T18:54:00.000-03:00</published><updated>2011-10-19T18:54:23.583-03:00</updated><title type='text'>Sarcoma granulocítico em medula espinhal e Sarcoma de Ewing em crânio de lactente - Posters Congresso Brasileiro de Pediatria 2011</title><summary type='text'>Este ano, o Congresso Brasileiro de Pediatria foi em Salvador, Bahia, entre 8 e 12 de Outubro de 2011. Pediatras do país inteiro compareceram, batendo recorde de audiência num congresso da Sociedade Brasileira de Pediatria. Numa parceria com alunos da Liga do Câncer da Universidade Federal do Ceará, enviamos 2 relatos de casos raros em oncologia pediátrica, em forma de poster.

Poster 1: Sarcoma </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4444474819323888775'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4444474819323888775'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/sarcoma-granulocitico-em-medula.html' title='Sarcoma granulocítico em medula espinhal e Sarcoma de Ewing em crânio de lactente - Posters Congresso Brasileiro de Pediatria 2011'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1254787009603070778</id><published>2011-10-19T16:12:00.001-03:00</published><updated>2011-10-19T18:57:51.039-03:00</updated><title type='text'>Analgesic effect of venlafaxine and antiplatelet efect of pulegone - FESBE 2011 posters</title><summary type='text'>The 2011 edition of the Annual Meeting of the Brazilian Federation of Experimental Biology Societies (FeSBE, Federação de Sociedades de Biologia Experimental) took place from August 24th through 27th, in Rio de Janeiro, Brazil. Scientists from all over the world attended this meeting. We sent two brief communications in poster form.

Poster 1: EVALUATION OF THE ANALGESIC EFFECT OF VENLAFAXINE, A </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1254787009603070778'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1254787009603070778'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/analgesic-effect-of-venlafaxine-and.html' title='Analgesic effect of venlafaxine and antiplatelet efect of pulegone - FESBE 2011 posters'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3457182050230951676</id><published>2011-10-15T11:42:00.002-03:00</published><updated>2011-10-15T11:42:38.494-03:00</updated><title type='text'>What's new for 'childhood cancer' in PubMed</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology 
Sender's message:  
Sent on Saturday, 2011 Oct 15
Search cancer 

Limits:Randomized Controlled Trial, All Child: 0-18 years





PubMed Results





1.A randomized controlled trial of propranolol for infantile hemangiomas.
Hogeling M,  Adams S,  Wargon O.
Pediatrics. 2011 Aug;128(2):e259-66. Epub 2011 Jul</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3457182050230951676'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3457182050230951676'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/whats-new-for-childhood-cancer-in.html' title='What&apos;s new for &apos;childhood cancer&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3820863323523266577</id><published>2011-10-15T11:32:00.000-03:00</published><updated>2011-10-15T11:32:23.730-03:00</updated><title type='text'>What's new for 'fibromyalgia' in PubMed - valproate analgesic effect, obesity, and more!</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology 
Sender's message: Search: fibromyalgia 
Sent on Saturday, 2011 Oct 08
Search fibromyalgia 




PubMed Results


1.Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults.
Gill D,  Derry S,  Wiffen PJ,  Moore RA.
Cochrane Database Syst Rev. 2011 Oct 5;10:CD009183.
PMID: 21975791 </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3820863323523266577'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3820863323523266577'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/whats-new-for-fibromyalgia-in-pubmed.html' title='What&apos;s new for &apos;fibromyalgia&apos; in PubMed - valproate analgesic effect, obesity, and more!'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2656953664171655646</id><published>2011-10-15T11:15:00.002-03:00</published><updated>2011-10-15T11:43:20.068-03:00</updated><title type='text'>What's new for 'angiotensin AND cancer' in PubMed - coffee, statins, ACE inhibitors and more!</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology
Sender's message:  
Sent on Saturday, 2011 Oct 08
Search angiotensin cancer 




PubMed Results

Items 1 - 4



1.Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
Tanaka N,  Miyajima A,  Kosaka T,  Miyazaki Y,  Shirotake S,  Shirakawa H,  </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2656953664171655646'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2656953664171655646'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/whats-new-for-angiotensin-and-cancer-in.html' title='What&apos;s new for &apos;angiotensin AND cancer&apos; in PubMed - coffee, statins, ACE inhibitors and more!'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7055079983824939809</id><published>2011-10-03T20:49:00.000-03:00</published><updated>2011-10-03T20:49:34.911-03:00</updated><title type='text'>Tratamento de Tumores Cerebrais no Hospital Infantil Albert Sabin</title><summary type='text'>Acaba de sair o trabalho do grupo de Oncologia Pediátrica e Neuro-oncologia clínica do Hospital Infantil Albert Sabin (HIAS), publicado no Jornal de Pediatria, da Sociedade Brasileira de Pediatria. O trabalho é uma avaliação retrospectiva da sobrevida dos pacientes pediátricos portadores de tumores cerebrais diagnosticados entre janeiro de 2000 e dezembro de 2006 no HIAS. Os autores, coordenados </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7055079983824939809'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7055079983824939809'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/tratamento-de-tumores-cerebrais-no.html' title='Tratamento de Tumores Cerebrais no Hospital Infantil Albert Sabin'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4663700943506808855</id><published>2011-10-01T23:03:00.000-03:00</published><updated>2011-10-01T23:16:55.489-03:00</updated><title type='text'>Valproate for cancer: the glioblastoma connection</title><summary type='text'>The treatment of brain cancer has just received a brand new hope from an old brother in arms: the anti-epileptic drug valproate, used frequently for seizures in children, and less frequently for patients with brain tumor, has shown an unexpected activity against a lethal brain cancer. The study, published in Neurology by the EORTC group in association with National Cancer Institute of Canada, </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4663700943506808855'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4663700943506808855'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/valproate-for-cancer-glioblastoma.html' title='Valproate for cancer: the glioblastoma connection'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4869209801525868756</id><published>2011-10-01T20:27:00.003-03:00</published><updated>2011-10-01T20:27:55.247-03:00</updated><title type='text'>What's new for 'cancer' in PubMed - pediatric oncology</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology
Sender's message:  
Sent on Saturday, 2011 Oct 01
Search cancer 

Limits:Randomized Controlled Trial, All Child: 0-18 years




PubMed Results




Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4869209801525868756'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4869209801525868756'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/whats-new-for-cancer-in-pubmed.html' title='What&apos;s new for &apos;cancer&apos; in PubMed - pediatric oncology'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3260122308280370189</id><published>2011-10-01T13:38:00.000-03:00</published><updated>2011-10-01T13:38:08.199-03:00</updated><title type='text'>A controvérsia dos prêmios internacionais em farmacologia - o passado do Brasil e a vez da China</title><summary type='text'>Há muitos exemplos de prêmios internacionais na área de medicina, em especial na área de farmacologia, que geram controvérsia pela nominação de um ou poucos cientistas de um grande grupo que contribuiu para uma descoberta. Um comentário do famoso farmacologista Ervin Erdös em um artigo seu publicado em 2006 (recomendado a quem quiser saber mais sobre a descoberta da enzima conversora de </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3260122308280370189'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3260122308280370189'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/10/controversia-dos-premios-internacionais.html' title='A controvérsia dos prêmios internacionais em farmacologia - o passado do Brasil e a vez da China'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-6838113509197352391</id><published>2011-09-26T18:32:00.001-03:00</published><updated>2011-09-26T18:32:51.824-03:00</updated><title type='text'>Família que janta unida... - Novidades de nutrição infantil da Pediatrics</title><summary type='text'>Novidades sobre nutrição infantil este mês na revista Pediatrics:Uma meta-análise incluindo mais de 180 mil crianças e adolescentes entre 3 e 17 anos mostrou que, se a família compartilha a mesa às refeições pelo menos três vezes por semana, o risco de erros alimentares e doenças endócrinas cai sensivelmente. O grupo de medicina da comunidade de Urbana, Illinois, concluiu em seu estudo que a </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6838113509197352391'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6838113509197352391'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/familia-que-janta-unida-novidades-de.html' title='Família que janta unida... - Novidades de nutrição infantil da Pediatrics'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3323680228101166609</id><published>2011-09-25T22:37:00.001-03:00</published><updated>2011-10-01T15:06:16.452-03:00</updated><title type='text'>Breast-Cancer Adjuvant Therapy with Zoledronic Acid - Online first in NEJM</title><summary type='text'>


Breast-Cancer Adjuvant Therapy with Zoledronic Acid

Robert  E. Coleman, M.B., B.S., M.D., Helen Marshall, M.Sc., David Cameron, M.B., B.S., M.D., David Dodwell, M.B., Ch.B., M.D., Roger Burkinshaw, B.Sc., Maccon Keane, M.D., Miguel Gil, M.D., Stephen J. Houston, M.B., B.S., M.D., Robert J. Grieve, M.B., Ch.B., Peter J. Barrett-Lee, M.B., B.S., M.D., Diana Ritchie, M.B., Ch.B., M.D., Julia </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3323680228101166609'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3323680228101166609'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/breast-cancer-adjuvant-therapy-with.html' title='Breast-Cancer Adjuvant Therapy with Zoledronic Acid - Online first in NEJM'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2252225121396035809</id><published>2011-09-24T09:04:00.001-03:00</published><updated>2011-09-24T09:04:26.410-03:00</updated><title type='text'>What's new for 'ACE inhibitors and cancer' in PubMed</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology
Sender's message:  
Sent on Saturday, 2011 Sep 24
Search angiotensin cancer 





PubMed Results





Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors,  ARBs,  and/or Statins.
Cancer Invest. 2011 Sep 21. [Epub ahead of print]
PMID: 21936625 [PubMed - as supplied by publisher]



</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2252225121396035809'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2252225121396035809'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/whats-new-for-ace-inhibitors-and-cancer_24.html' title='What&apos;s new for &apos;ACE inhibitors and cancer&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7385596148560381398</id><published>2011-09-21T17:36:00.001-03:00</published><updated>2011-09-21T17:36:12.159-03:00</updated><title type='text'>Aceita um pouco de peixe?</title><summary type='text'>A carne de peixe é muito apreciada como uma alternativa de elevado teor nutricional, saborosa e, ao mesmo tempo, saudável. O consumo da carne de peixes ricos em óleos ômega-3 pode proteger de doenças cardiovasculares. No entanto, não existem avaliações sobre a influência do modo de preparo do peixe na saúde dos consumidores. Um estudo publicado em maio deste ano no periódico Circulation (American</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7385596148560381398'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7385596148560381398'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/aceita-um-pouco-de-peixe.html' title='Aceita um pouco de peixe?'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8901587449438132378</id><published>2011-09-21T16:15:00.001-03:00</published><updated>2011-09-21T16:15:28.680-03:00</updated><title type='text'>Omega 3 melhora Hiperatividade - via Revista de Neurologia</title><summary type='text'>Suplementos de ácidos graxos ômega-3 podem reduzir os sintomas do transtorno de déficit de atenção e hiperatividade (TDAH) em crianças, conforme publicado no Journal of Child Psychology and Psychiatry. Em uma avaliação de 10 estudos com um total de 699 crianças com TDAH, os pesquisadores descobriram que aquelas que receberam suplementos omega-3 mostraram uma melhora pequena, mas significativa na </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8901587449438132378'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8901587449438132378'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/omega-3-melhora-hiperatividade-via.html' title='Omega 3 melhora Hiperatividade - via Revista de Neurologia'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8176749146337187314</id><published>2011-09-20T22:19:00.000-03:00</published><updated>2011-09-20T22:21:24.923-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='propranolol'/><category scheme='http://www.blogger.com/atom/ns#' term='antiangiogênico'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='novas drogas'/><category scheme='http://www.blogger.com/atom/ns#' term='hemangiomas'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='mal-formações'/><category scheme='http://www.blogger.com/atom/ns#' term='publicações'/><title type='text'>Tratamento de hemangiomas no Hospital Infantil Albert Sabin</title><summary type='text'>A Revista de Saúde da Criança e do Adolescente deste mês traz um artigo de minha autoria descrevendo as opções no tratamento de crianças com hemangioma. Este artigo é baseado em  minha experiência pessoal, de ter tratado no Serviço de Onco-hematologia Pediátrica do Hospital Infantil Albert Sabin (agora Centro Pediátrico do Câncer) mais de 200 crianças com hemangiomas nos últimos 5 anos. O </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8176749146337187314'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8176749146337187314'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/tratamento-de-hemangiomas-no-hospital.html' title='Tratamento de hemangiomas no Hospital Infantil Albert Sabin'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3043535654020617500</id><published>2011-09-18T22:51:00.000-03:00</published><updated>2011-09-18T22:52:27.565-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='prevenção'/><category scheme='http://www.blogger.com/atom/ns#' term='estilo de vida'/><category scheme='http://www.blogger.com/atom/ns#' term='pressão arterial'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='dor'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='publicações'/><title type='text'>A Música e a Fera - Musicoterapia diminui ansiedade e dor em portadores de câncer</title><summary type='text'>Uma nova meta-análise da Cochrane Library avaliou o impacto da musicoterapia nos sintomas e qualidade de vida de pacientes portadores de câncer. A terapeuta Joke Brandt, da Drexel University, Philadelphia, e sua equipe avaliaram 30 estudos publicados sobre musicoterapia em pacientes com câncer. Os resultados da análise mostraram que a musicoterapia teve um efeito benéfico em escores padronizados </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3043535654020617500'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3043535654020617500'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/musica-e-fera-musicoterapia-diminui.html' title='A Música e a Fera - Musicoterapia diminui ansiedade e dor em portadores de câncer'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4983127546715238357</id><published>2011-09-17T20:38:00.001-03:00</published><updated>2011-09-18T12:22:44.844-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='aulas'/><category scheme='http://www.blogger.com/atom/ns#' term='Lectures'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Aula de Oncologia</title><summary type='text'>No dia 15 de setembro, quinta-feira última, ministrei a aula "Avanços no tratamento de tumores neurológicos em crianças", como parte do IV Curso de Abordagem Clínica em Oncologia - Atualizações sobre o Estudo do Câncer, a convite da Liga do Câncer - UFC. A aula ocorreu no auditório da Oncoclinic, no Harmony Center, em Fortaleza - CE. Agradeço o convite à comissão organizadora do evento e ao </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4983127546715238357'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4983127546715238357'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/aula-de-oncologia.html' title='Aula de Oncologia'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7132055729253211003</id><published>2011-09-17T12:54:00.000-03:00</published><updated>2011-09-18T12:24:40.374-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='pubmed'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>What's new for 'ACE inhibitors and cancer' in PubMed</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology
Sender's message:  
Sent on Saturday, 2011 Sep 17
Search angiotensin cancer 





PubMed Results

Item 1 of 1



1.Angiotensin converting enzyme inhibitors and hepatocellular carcinoma incidence in the General Practice Research Database.
Walker AJ,  West J,  Grainge MJ,  Card TR.
Cancer Causes Control. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7132055729253211003'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7132055729253211003'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/whats-new-for-ace-inhibitors-and-cancer.html' title='What&apos;s new for &apos;ACE inhibitors and cancer&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7610246283074909252</id><published>2011-09-16T23:08:00.000-03:00</published><updated>2011-09-18T12:58:11.723-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='immunology'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='flu'/><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='science'/><title type='text'>The Enemy Within - Unexpected Cell Type Orchestrate Immune Turmoil in Flu - via ScienceNow</title><summary type='text'>When a patient gets killed by a specially lethal kind of flu, as in the recent outbreaks of H1N1 or H5N1 (swine and avian) strains of flu virus, it might be the body's own defenses that make the final move. The flu and other infections can provoke so-called  cytokine storms or immunological storms. One hallmark of these events is  a surge of chemical messengers called cytokines and chemokines </summary><link rel='related' href='http://news.sciencemag.org/sciencenow/2011/09/surprising-cells-rein-in-killer-.html?ref=em&amp;elq=0dec6a42e0234ec68c056940969bc06d#.TnP8Lpot1pU.blogger' title='The Enemy Within - Unexpected Cell Type Orchestrate Immune Turmoil in Flu - via ScienceNow'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7610246283074909252'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7610246283074909252'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/enemy-within-unexpected-cell-type.html' title='The Enemy Within - Unexpected Cell Type Orchestrate Immune Turmoil in Flu - via ScienceNow'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2643770879595960080</id><published>2011-09-13T00:16:00.000-03:00</published><updated>2011-09-18T12:59:07.043-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><title type='text'>TV Burrinho? Relação entre o formato dos cartoons e cognição infantil</title><summary type='text'>A geração das pessoas que têm entre 30-40 anos tem sido chamada de "imigrantes digitais", em contraposição a seus filhos, os "nativos digitais", denotando que as crianças tipicamente começam a ser expostas à TV com menos de 1 ano hoje, assistindo uma média de 6-8 horas de TV ao dia (dados dos EUA). Seus pais, ao contrário, tiveram contato com a TV bem mais velhos e foram expostos a uma quantidade</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2643770879595960080'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2643770879595960080'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/tv-burrinho-relacao-entre-o-formato-dos.html' title='TV Burrinho? Relação entre o formato dos cartoons e cognição infantil'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-5282822121884916238</id><published>2011-09-12T22:47:00.000-03:00</published><updated>2011-09-18T12:18:10.527-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>The hidden target - a new cancer immunotherapy?</title><summary type='text'>In the last issue of Science Translational Medicine, a team from the National University of Singapore report the intriguing finding that intracellular tumor antigen–specific monoclonal antibodies could inhibit tumor
                        growth and metastasis and prolong survival of tumor-bearing mice. As this is a dogma-challenging discovery, a lot of questions naturally arise. Just how the </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5282822121884916238'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5282822121884916238'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/hidden-target-new-cancer-immunotherapy.html' title='The hidden target - a new cancer immunotherapy?'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3408900618631574927</id><published>2011-09-12T20:57:00.000-03:00</published><updated>2011-09-12T20:57:12.276-03:00</updated><title type='text'>Oxidative stress and cardiovascular disease</title><summary type='text'>A set of reviews about the role of oxidative stress-related injury in the genesis of cardiovascular disease are some of the most popular recently published papers in the American Journal of the Medical Sciences. They are the transcription of lectures presented in a symposium held as part of the annual scientific session of the Southern Society for Clinical Investigation. Internationally </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3408900618631574927'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3408900618631574927'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/oxidative-stress-and-cardiovascular.html' title='Oxidative stress and cardiovascular disease'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8355065478475138786</id><published>2011-09-10T13:16:00.002-03:00</published><updated>2011-09-18T12:24:40.386-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='pubmed'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>What's new for 'cancer' in PubMed</title><summary type='text'>
From Pubmed latest published:


Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.

Schaich M,  Röllig C,  Soucek S,  Kramer M,  Thiede C,  Mohr B,  Oelschlaegel U,  Schmitz N,  Stuhlmann R,  Wandt H,  Schäfer-Eckart K,  Aulitzky W,  Kaufmann M,  Bodenstein H,  Tischler J</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8355065478475138786'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8355065478475138786'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/whats-new-for-cancer-in-pubmed.html' title='What&apos;s new for &apos;cancer&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3111014323938780367</id><published>2011-09-10T13:12:00.000-03:00</published><updated>2011-09-18T12:27:16.246-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pubmed'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>What's new for 'fibromyalgia' in PubMed</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology
Sender's message: Search: fibromyalgia 
Sent on Saturday, 2011 Sep 10
Search fibromyalgia 

(Selected results only)



PubMed Results





1.Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia.
Smith SB,  Maixner DW,  Fillingim RB,  Slade G,  Gracely</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3111014323938780367'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3111014323938780367'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/whats-new-for-fibromyalgia-in-pubmed.html' title='What&apos;s new for &apos;fibromyalgia&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-5287637488513505411</id><published>2011-09-10T12:51:00.000-03:00</published><updated>2011-09-18T12:58:11.713-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><title type='text'>Concurso 'Dance Your Ph.D.' 2011 - via ScienceNOW</title><summary type='text'>A revista Science divulgou a nova edição de seu concurso anual "Dance Your PhD", no seu blog de notícias, ScienceNOW. O concurso é um desafio bem-humorado a cientistas com doutorado ou estudantes de doutorado de explicar ou expressar sua tese, sua pesquisa e resultados na forma de uma coreografia de dança. É um concurso amador e sem pretensões artísticas, o propósito é a diversão, mas que tem um </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5287637488513505411'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5287637488513505411'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/concurso-dance-your-phd-2011-via.html' title='Concurso &apos;Dance Your Ph.D.&apos; 2011 - via ScienceNOW'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3049913101609576890</id><published>2011-09-10T12:33:00.000-03:00</published><updated>2011-09-10T12:33:09.650-03:00</updated><title type='text'>Bird Flu is comming back</title><summary type='text'>The United Nations Food and Agriculture Organization (FAO)  issued a bulletin last week that stirred a lot of press attention. It warned of “a major resurgence                      of the H5N1 highly pathogenic avian influenza amid  signs that a mutant strain of the deadly bird flu virus is spreading in                      Asia and beyond, with unpredictable risks to human  health.” Other </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3049913101609576890'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3049913101609576890'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/bird-flu-is-comming-back.html' title='Bird Flu is comming back'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2445390266355392298</id><published>2011-09-08T23:15:00.003-03:00</published><updated>2011-09-23T17:40:06.143-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Aula do projeto Protocolos 2011</title><summary type='text'>Hoje, no Centro pediátrico do Câncer, iniciamos o projeto Protocolos 2011 com uma exposição minha sobre o tratamento clínico de tumores do Sistema Nervoso Central. O projeto Protocolos 2011 foi solicitado pela direção do Hospital Infantil Albert Sabin, na pessoa da Dra. Joana Angélica de Paiva Maciel, para padronizar as condutas no CPC. A exposição inclui um breve histórico, uma avaliação da </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2445390266355392298'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2445390266355392298'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/aula-do-projeto-protocolos-2011.html' title='Aula do projeto Protocolos 2011'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2694780522011165656</id><published>2011-09-06T22:39:00.001-03:00</published><updated>2011-09-18T12:18:10.500-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>XIII Congresso Brasileiro de Oncologia Pediátrica</title><summary type='text'>Em 2012, o congresso da Sociedade Brasileira de Oncologia Pediátrica - SOBOPE, será em Natal, de 17 a 20 de abril. Com presidência do Dr. Elione Soares de Albuquerque e apoio do Instituto Ronald McDonald, Casa Durval Paiva e AAPCMR, será uma oportunidade para que os colegas façam contatos e reciclagem. Visite a página do congresso: http://bit.ly/pDxgt0</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2694780522011165656'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2694780522011165656'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/xiii-congresso-brasileiro-de-oncologia.html' title='XIII Congresso Brasileiro de Oncologia Pediátrica'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8755347295249490333</id><published>2011-09-06T19:38:00.000-03:00</published><updated>2011-09-18T12:58:11.739-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><title type='text'>I, Robot</title><summary type='text'>Via ScienceNOW: Robotic avatars of disabled people walking around and interacting with other people? This possibility has now a little more of science and a little less of fiction due to a new development reported at IEEE Engineering in Medicine and Biology Society conference in Boston. A group from  École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland has devised a way of merging </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8755347295249490333'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8755347295249490333'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/i-robot.html' title='I, Robot'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-570991511209851824</id><published>2011-09-03T17:41:00.000-03:00</published><updated>2011-09-18T12:22:44.851-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='aulas'/><category scheme='http://www.blogger.com/atom/ns#' term='Lectures'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Atualização da aula "Câncer em Crianças"</title><summary type='text'>A aula apresentada no CRIO em maio deste ano, intitulada "Câncer em Crianças", havia sido disponibilizada para visualização online a quem dispusesse do link. Esta primeira versão foi montada sem os créditos das diversas imagens que utilizamos. Agora, uma nova versão está pronta, contendo créditos e links para as imagens. A visualização da nova versão é possível aqui: http://bit.ly/qovrvg
</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/570991511209851824'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/570991511209851824'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/09/atualizacao-da-aula-cancer-em-criancas.html' title='Atualização da aula &quot;Câncer em Crianças&quot;'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7516078168678220980</id><published>2011-08-30T20:08:00.000-03:00</published><updated>2011-09-18T12:29:09.757-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pubmed'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>What's new for 'cancer' in PubMed</title><summary type='text'>Search cancer 
Limits:Randomized Controlled Trial, All Child: 0-18 years

PubMed Results
Items 1 - 4 of 4

1.Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
García-Del-Muro X,  López-Pousa A,  Maurel J,  Martín J,  Martínez-Trufero J,  Casado A,  </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7516078168678220980'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7516078168678220980'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/whats-new-for-cancer-in-pubmed.html' title='What&apos;s new for &apos;cancer&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2819059142041956179</id><published>2011-08-26T23:33:00.002-03:00</published><updated>2011-09-18T12:29:09.577-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><title type='text'>Charlie and the Organ Factory - A Fantástica Fábrica de Órgãos</title><summary type='text'>Fiction? Fact? Hearts and livers on a pharmacy shelf may be a long way from now, but some people are already living with lab made organs. Americans are living with lab-grown bladders and europeans have received implanted lab made tracheas. An article published on Science this week has revealed that US regulatory agency FDA has given the approval for a new trial in US that is going to implant </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2819059142041956179'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2819059142041956179'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/charlie-and-organ-factory-fantastica.html' title='Charlie and the Organ Factory - A Fantástica Fábrica de Órgãos'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-6704786393128860617</id><published>2011-08-25T23:28:00.001-03:00</published><updated>2011-08-25T23:33:17.389-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='imagem'/><category scheme='http://www.blogger.com/atom/ns#' term='glioblastoma'/><category scheme='http://www.blogger.com/atom/ns#' term='quimioterapia'/><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores cerebrais'/><category scheme='http://www.blogger.com/atom/ns#' term='targeted therapy'/><category scheme='http://www.blogger.com/atom/ns#' term='brain tumor'/><title type='text'>Novidades na avaliação de neuro-imagens de tumores cerebrais</title><summary type='text'>Um novo artigo de consenso recém-publicado na rede pelo jornal Neurosurgery traz uma nova proposta de critérios de resposta após cirurgia para tumores cerebrais. O trabalho reuniu grandes nomes da neurocirurgia e neuro-oncologia da América do Norte e Europa e se propôs a atualizar o conjunto de critérios universalmente aceito até hoje, chamado de "Critérios de McDonald". O grupo de trabalho, </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6704786393128860617'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6704786393128860617'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/novidades-na-avaliacao-de-neuro-imagens.html' title='Novidades na avaliação de neuro-imagens de tumores cerebrais'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4121619042547402145</id><published>2011-08-20T13:13:00.000-03:00</published><updated>2011-08-20T13:13:49.679-03:00</updated><title type='text'>Redes sociais de quarentena</title><summary type='text'>O Conselho Federal de Medicina publicou nova resolução que regulamenta o uso publicitário da internet, blogs e redes sociais para divulgação do trabalho médico. Segundo o CFM,  “além de detalhamentos, a nova resolução se  diferencia da anterior por proibir expressamente ao médico a oferta de  consultoria a pacientes e familiares em substituição à consulta médica  presencial. Esta proibição se </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4121619042547402145'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4121619042547402145'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/redes-sociais-de-quarentena.html' title='Redes sociais de quarentena'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8641998697052798593</id><published>2011-08-15T17:09:00.001-03:00</published><updated>2011-08-15T17:09:45.417-03:00</updated><title type='text'>Introdução da dieta na diarréia aguda da infância</title><summary type='text'>Uma das doenças mais frequentes e de maior morbi-mortalidade em crianças de países e regiões em desenvolvimento é a diarréia aguda. Ela é responsável por uma proporção muito importante da mortalidade infantil no mundo inteiro. Apesar de existirem recomendações sobre o manejo da diarréia aguda publicadas pela OMS, pela OPAS (Organização Pan-Americana de Saúde) e pelo Ministério da Saúde do Brasil,</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8641998697052798593'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8641998697052798593'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/introducao-da-dieta-na-diarreia-aguda.html' title='Introdução da dieta na diarréia aguda da infância'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8981900284205237295</id><published>2011-08-15T12:08:00.001-03:00</published><updated>2011-09-18T12:18:10.571-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Novel immunotherapy has potent antitumor effect</title><summary type='text'>It has been highly publicized in media in the past days: 3 patients with an advanced and refractory type of leukemia have been cured by a new immune treatment. What are the science facts behind these news? A group of scientists from University of Pennsylvania, Philadelphia, have managed to develop a new kind of therapy using modified immune cells - an immunotherapy. They created genetically </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8981900284205237295'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8981900284205237295'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/novel-immunotherapy-has-potent.html' title='Novel immunotherapy has potent antitumor effect'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1183516072008453170</id><published>2011-08-15T11:32:00.001-03:00</published><updated>2011-09-18T12:18:10.468-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Glutamine will not save you from mucositis</title><summary type='text'>Glutamine solutions are often used for mucositis prevention in patients after stem-cell transplantation. A novel study has shown, however, that glutamine enriched parenteral nutrition did not affect mucosal morbidity or complicatiuons in kids that had undergone allogeneic hematopoietic stem-cell transplantation (HSCT) for malignant hematological diseases. The italian study, held in Monza, </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1183516072008453170'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1183516072008453170'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/glutamine-will-not-save-you-from.html' title='Glutamine will not save you from mucositis'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-872567013934911749</id><published>2011-08-05T19:34:00.001-03:00</published><updated>2011-09-18T12:29:09.793-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='propranolol'/><category scheme='http://www.blogger.com/atom/ns#' term='antiangiogênico'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='novas drogas'/><category scheme='http://www.blogger.com/atom/ns#' term='hemangiomas'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='ciência'/><category scheme='http://www.blogger.com/atom/ns#' term='publicações'/><title type='text'>Propranolol é eficaz e seguro para hemangiomas - provado por novo estudo</title><summary type='text'>O mais novo estudo sobre o uso de propranolol para o tratamento de hemangiomas infantis foi publicado online no portal do jornal Pediatrics, da American Academy of Pediatrics. Marcia Hogelling, Susan Adams e Orli Wargon, do Sydney Children's Hospital na Australia, trataram 40 crianças entre 9 semanas e 5 anos de idade, com hemangiomas faciais ou em outros locais desfigurantes. Os pacientes foram </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/872567013934911749'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/872567013934911749'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/08/propranolol-e-eficaz-e-seguro-para.html' title='Propranolol é eficaz e seguro para hemangiomas - provado por novo estudo'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1363058658070920730</id><published>2011-07-31T10:50:00.001-03:00</published><updated>2011-09-18T12:18:10.474-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Dor crônica em pacientes com câncer</title><summary type='text'>Revisão sobre dor oncológica publicada agora no Lancet:O manejo adequado da dor em pacientes com câncer produz alívio satisfatório para a maioria. No entanto, estima-se que 43% dos pacientes com câncer recebe cuidados inadequados para a sua dor. A base do tratamento na terapia farmacológica da dor oncológica são os opiáceos e todos os médicos devem tentar otimizar os resultados positivos dessas </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1363058658070920730'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1363058658070920730'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/dor-cronica-em-pacientes-com-cancer.html' title='Dor crônica em pacientes com câncer'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1945240507647689772</id><published>2011-07-31T10:45:00.001-03:00</published><updated>2011-09-18T12:18:10.483-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Papel de células tronco gliais na angiogênese tumoral</title><summary type='text'>Muitas evidências apoiam a hipótese de que células-tronco gliais estão intimamente relacionadas com o início da angiogênese, o fenômeno da hipóxia e da rede microvascular intratumoral neoplásicas. Este trabalho, publicado na Revista de Neurología, analisou o papel das células-tronco gliais em relação ao processo de angiogênese, bem como alguns resultados que se relacionam com o aparecimento </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1945240507647689772'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1945240507647689772'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/papel-de-celulas-tronco-gliais-na.html' title='Papel de células tronco gliais na angiogênese tumoral'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7522227186699764205</id><published>2011-07-31T10:38:00.001-03:00</published><updated>2011-09-18T12:32:17.758-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='temozolomide'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores cerebrais'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='temozolamida'/><category scheme='http://www.blogger.com/atom/ns#' term='brain tumor'/><title type='text'>Temozolomida melhora estado funcional de idosos com glioblastoma</title><summary type='text'>Temozolomida melhora a sobrevida e melhora a função e qualidade de vida em pacientes idosos com glioblastoma multiforme (GBM) recentemente diagnosticado, de acordo com resultados obtidos em um ensaio fase II publicado no Journal of Clinical Oncology. Um terço dos pacientes no estudo experimentaram melhorias no status funcional e um quarto deles tinham capacidade de cuidar de si mesmos após o </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7522227186699764205'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7522227186699764205'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/temozolomida-melhora-estado-funcional.html' title='Temozolomida melhora estado funcional de idosos com glioblastoma'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3341072658133049630</id><published>2011-07-23T14:18:00.002-03:00</published><updated>2011-07-25T10:44:19.574-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='vaccine'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='vacina'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><title type='text'>Vaccine design at atomic level</title><summary type='text'>Scientists from Novartis Italy-based facilities have reported in this month on Science Translational Medicine how they have probed an even deeper scale in the design of a new vaccine. Searching for a useful vaccine against meningococcus B, they combined conventional immunogen design, genomics and atomic structural information that led to a novel level of design refinement. Meningococcus is a </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3341072658133049630'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3341072658133049630'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/vaccine-design-at-atomic-level.html' title='Vaccine design at atomic level'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3359550266904472896</id><published>2011-07-21T19:01:00.000-03:00</published><updated>2011-09-18T12:18:10.507-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Beta bloqueadores e o tratamento do câncer</title><summary type='text'>Recentemente, 2 artigos publicados no Journal of Clinical Oncology (link 1 e 2) relataram que pacientes com câncer de mama que usam beta bloqueadores (como o propranolol), uma classe de drogas largamente utilizada para tratar hipertensão, têm menos recorrência tumoral e maior sobrevida livre de doença, e também que pacientes usando estas drogas apresentam um risco menor de desenvolver câncer de </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3359550266904472896'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3359550266904472896'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/beta-bloqueadores-e-o-tratamento-do.html' title='Beta bloqueadores e o tratamento do câncer'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://img.youtube.com/vi/YrEq99p5HQ0/default.jpg' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4334643547935963593</id><published>2011-07-18T20:17:00.000-03:00</published><updated>2011-09-18T12:58:11.704-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><title type='text'>The Running Mice</title><summary type='text'>Researchers of the University of Pennsylvania and his colleagues genetically engineered mice to lack the IL-15Rα gene, and the modified mice ran six times farther than normal mice each night. Previous studies had suggested that IL-15Rα is important for muscle strength. The genetically-modified mice seemed to lack fast-twitch muscles - muscles that allow more precise movements but tire faster - </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4334643547935963593'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4334643547935963593'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/running-mice.html' title='The Running Mice'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2660268222167885996</id><published>2011-07-17T22:18:00.008-03:00</published><updated>2011-09-18T12:29:09.570-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='imunoterapia'/><category scheme='http://www.blogger.com/atom/ns#' term='novas drogas'/><category scheme='http://www.blogger.com/atom/ns#' term='neuroblastoma'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='targeted therapy'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>First effective immunotherapy for high-risk neuroblastoma</title><summary type='text'>A team led by San Diego medical researcher Alice Yu published in New England Journal of Medicine their break-through results of the first ever immunotherapy proved to be effective for high-risk neuroblastoma patients. This new treatment was first announced in the 2009 edition of ASCO meeting (see previous post). Children with this disease normally have a grim prognosis. Yu's group treated </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2660268222167885996'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2660268222167885996'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/first-effective-immunotherapy-for-high.html' title='First effective immunotherapy for high-risk neuroblastoma'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3106969107041088217</id><published>2011-07-17T21:10:00.005-03:00</published><updated>2011-09-18T12:29:09.601-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='neuroblastoma'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='quimioterapia'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><title type='text'>Intermediate-risk neuroblastoma has good prognosis</title><summary type='text'>Neuroblastoma, a tumor that affects mostly young children and has a very high mortality rate when advanced, has been shown in a study published in 2010 that can have good prognosis with reduced chemotherapy. The study, announced for the first time in 2007 (see this previous post) was led by a team from Perth, Australia and endorsed by Childrens Oncology Group. They used the COG risk </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3106969107041088217'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3106969107041088217'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/intermediate-risk-neuroblastoma-has.html' title='Intermediate-risk neuroblastoma has good prognosis'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2492162481901784712</id><published>2011-07-17T11:30:00.002-03:00</published><updated>2011-09-18T12:29:09.551-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='neuroblastoma'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='quimioterapia'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='anticâncer'/><title type='text'>High-dose chemotherapy and stem cell transplant for advanced neuroblastoma</title><summary type='text'>Results from a french pilot trial testing very high dose chemotherapy followed by autologous transplantation in children with advanced neuroblastoma were not different from previous trials with other approaches. Survival in this group of patients remained between 30-40% in 5 years. New treatments are needed for kids with advanced neuroblastoma.

A dose-intensive approach (NB96) for induction </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2492162481901784712'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2492162481901784712'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/dose-intensive-approach-nb96-for.html' title='High-dose chemotherapy and stem cell transplant for advanced neuroblastoma'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-5516608790117236744</id><published>2011-07-17T10:34:00.002-03:00</published><updated>2011-09-18T12:29:09.700-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='neuroblastoma'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='quimioterapia'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='anticâncer'/><title type='text'>Advanced neuroblastoma treated with 131I-MIBG and combined chemotherapy</title><summary type='text'>A group from Italy has just published results from a trial using Radio-iodine MIBG to treat kids with advanced neuroblastoma. They report better results with association to chemotherapy. This initial report may yield new clinical trials using this combination to test it's efficacy against this grim disease.

Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5516608790117236744'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/5516608790117236744'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/treatment-of-advanced-neuroblastoma-in.html' title='Advanced neuroblastoma treated with 131I-MIBG and combined chemotherapy'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-829070766454794449</id><published>2011-07-16T11:14:00.001-03:00</published><updated>2011-09-18T12:58:11.731-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><title type='text'>Bacteria Flash Like Christmas Lights - ScienceNOW</title><summary type='text'>Cool blinking bacteria allow scientists to discover a whole new electrophysiological phenomenon. Bacteria can depolarize like neurons do, a group of scientists who were studying neurons discovered by chance. See the cool video showing flashing live bacteria in Science web page.

Bacteria Flash Like Christmas Lights - ScienceNOW</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/829070766454794449'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/829070766454794449'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/bacteria-flash-like-christmas-lights.html' title='Bacteria Flash Like Christmas Lights - ScienceNOW'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4458925941838120492</id><published>2011-07-05T19:25:00.000-03:00</published><updated>2011-07-05T19:25:51.093-03:00</updated><title type='text'>EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision - Attal - 2010 - European Journal of Neurology - Wiley Online Library</title><summary type='text'>European Federation of Neurological Societies updated guidelines for the management of neuropathic pain. This second EFNS Task Force aimed at updating the existing evidence about the pharmacological treatment of neuropathic pain since 2005. In its conclusions, it declares that there are still too few large-scale comparative studies, and more studies are needed. For future trials, EFNS recommend </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4458925941838120492'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4458925941838120492'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/efns-guidelines-on-pharmacological.html' title='EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision - Attal - 2010 - European Journal of Neurology - Wiley Online Library'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-9167881319176493710</id><published>2011-07-05T06:45:00.000-03:00</published><updated>2011-09-18T12:58:11.755-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Magnetic Nanoparticles Fry Tumors - ScienceNOW</title><summary type='text'>In a new study, a team from Korea found that injecting mice with tiny magnets and cranking up the heat eliminated tumors from the animals' bodies with no apparent side effects.The idea of killing cancer with heat isn't new. Like normal cells, cancer cells start to die when body temperature rises above 43˚C. The trick is figuring out how to kill the cancer without harming the body's own cells. One</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9167881319176493710'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9167881319176493710'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/magnetic-nanoparticles-fry-tumors.html' title='Magnetic Nanoparticles Fry Tumors - ScienceNOW'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-9073868424923183380</id><published>2011-07-02T23:32:00.001-03:00</published><updated>2011-09-18T12:29:09.811-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><title type='text'>New Cochrane meta-analysis sparks controversy about bronchiolitis</title><summary type='text'>Bronchiolitis is the most common disease of the lower respiratory tract during the first year of life. Respiratory syncytial virus is the underlying cause of most bronchiolitis and this infection is associated with substantial                                 morbidity in young children. Research has shown its burden in developed and developing countries and a lack of</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9073868424923183380'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9073868424923183380'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/new-cochrane-meta-analysis-sparks.html' title='New Cochrane meta-analysis sparks controversy about bronchiolitis'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8020456037714588981</id><published>2011-07-02T11:05:00.000-03:00</published><updated>2011-09-18T12:29:09.765-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='atopia'/><category scheme='http://www.blogger.com/atom/ns#' term='asma'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='asthma'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><title type='text'>Burying Anti-leukotrienes</title><summary type='text'>A recently published meta-analisys from Cochrane Database has reported that anti-leukotriene drugs fare worse than long-acting beta2-adrenergics when treating adults with inhaled-corticosteroid resistant asthma. Although this report coiós not conclude anything for children, anti-leukotrienes are known to have limited value in pediatric asthma. This result makes an even stronger case for the fail </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8020456037714588981'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8020456037714588981'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/burying-anti-leukotrienes.html' title='Burying Anti-leukotrienes'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3891302183122839076</id><published>2011-07-02T08:20:00.017-03:00</published><updated>2011-09-18T12:29:09.626-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='genetics'/><category scheme='http://www.blogger.com/atom/ns#' term='imunossupressores'/><category scheme='http://www.blogger.com/atom/ns#' term='macrophage activation syndrome'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pubmed'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='hemophagocytic lymphohistiocytosis'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='mortalidade'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='science'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='publicações'/><title type='text'>What's new this month for 'macrophage activation syndrome' in PubMed</title><summary type='text'>This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).

Sender's message: Search: macrophage activation syndrome 
Sent on Saturday, 2011 Jul 02
Search macrophage activation syndrome 



PubMed Results


1.Adult-onset Still's disease with macrophage activation syndrome successfully treated </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3891302183122839076'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3891302183122839076'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/07/whats-new-this-month-for-macrophage.html' title='What&apos;s new this month for &apos;macrophage activation syndrome&apos; in PubMed'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-6307294068509184770</id><published>2011-06-30T18:33:00.001-03:00</published><updated>2011-07-02T11:17:20.402-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='bevacizumab'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='avastin'/><category scheme='http://www.blogger.com/atom/ns#' term='targeted therapy'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='anticâncer'/><title type='text'>Breast Cancer Drug Gets a Unanimous Thumbs Down - ScienceInsider</title><summary type='text'>An advisory committee to the U.S. Food and Drug Administration (FDA) sided this afternoon with the agency, agreeing in a unanimous vote, 6-0, that the drug Avastin should not be approved for breast cancer. Although FDA doesn't have to side with its advisory committee, in this case it's likely to do so since it made a similar decision back in December. Agency officials reiterated their case </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6307294068509184770'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6307294068509184770'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/06/breast-cancer-drug-gets-unanimous.html' title='Breast Cancer Drug Gets a Unanimous Thumbs Down - ScienceInsider'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-9030980797258654769</id><published>2011-06-30T15:34:00.001-03:00</published><updated>2011-09-18T12:58:11.747-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='genetics'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='rapamycin'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='targeted therapy'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='novas drogas'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='mal-formações'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>New Drug Hope for 'Aging' Kids - ScienceNOW</title><summary type='text'>A drug approved to treat cancer and prevent the rejection of transplanted organs may also help children with progeria—a disease that resembles accelerated aging and typically kills those afflicted by their teens—according to a new study. The drug's effects on cells from these children is so striking, and the condition so devastating, that physicians and scientists are debating whether to proceed </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9030980797258654769'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/9030980797258654769'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/06/new-drug-hope-for-aging-kids-sciencenow.html' title='New Drug Hope for &apos;Aging&apos; Kids - ScienceNOW'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1210620782940904457</id><published>2011-06-22T18:08:00.003-03:00</published><updated>2011-09-18T12:58:11.695-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='prevenção'/><category scheme='http://www.blogger.com/atom/ns#' term='estilo de vida'/><category scheme='http://www.blogger.com/atom/ns#' term='ambiente'/><category scheme='http://www.blogger.com/atom/ns#' term='risco'/><category scheme='http://www.blogger.com/atom/ns#' term='ScienceNOW'/><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><category scheme='http://www.blogger.com/atom/ns#' term='science'/><category scheme='http://www.blogger.com/atom/ns#' term='ciência'/><title type='text'>The Mental Hazards of City Living - ScienceNOW</title><summary type='text'> Provocative new study says urban life alters the way the brain handles social stress.                      
 Psychiatrist Andreas Meyer-Lindenberg and collaborators at the Central  Institute of Mental Health and the University of Heidelberg Medical  Faculty in Mannheim, Germany, have previously used brain-imaging methods  to search for abnormalities in the brains of people with genetic risk </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1210620782940904457'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1210620782940904457'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/06/mental-hazards-of-city-living.html' title='The Mental Hazards of City Living - ScienceNOW'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8184589956104736468</id><published>2011-06-22T17:13:00.008-03:00</published><updated>2011-09-18T12:29:09.775-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='aulas'/><category scheme='http://www.blogger.com/atom/ns#' term='Lectures'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='targeted therapy'/><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='novas drogas'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Aulas da Pós-Graduação</title><summary type='text'>Caros alunos da disciplina de Farmacologia Molecular e Autonômica, turma 2011.1, Programa de Pós-Graduação em Ciências Farmacêuticas, estes são os links dos artigos científicos correspondentes à aula do dia 14/07/2011 (confirmado). Cada link dá acesso a um artigo. Um deles é de revisão e os outros 4 são artigos originais. Dois são sobre farmacogenômica enfocando a oncologia e os outros 3 são </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8184589956104736468'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8184589956104736468'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/06/aulas-da-pos-graduacao.html' title='Aulas da Pós-Graduação'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-6915698438859120438</id><published>2011-05-28T17:31:00.001-03:00</published><updated>2011-09-18T12:22:44.974-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores pediátricos'/><category scheme='http://www.blogger.com/atom/ns#' term='aulas'/><category scheme='http://www.blogger.com/atom/ns#' term='novas drogas'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='Lectures'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Aula de Câncer em Crianças</title><summary type='text'>Nesta quarta, dia 25 de maio, apresentei uma aula no CRIO - Centro Regional Integrado de Oncologia (home: http://www.crio.com.br/) a convite do dr. Igor Moreira Veras e da comissão organizadora do I Ciclo de Palestras do Centro de Estudos do CRIO. O tema foi "Câncer em Crianças". Postarei o link para download da aula.</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6915698438859120438'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/6915698438859120438'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/05/aula-de-cancer-em-criancas.html' title='Aula de Câncer em Crianças'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7219899890950823690</id><published>2011-04-23T16:26:00.001-03:00</published><updated>2011-09-18T12:29:09.733-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='targeted therapy'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='anticâncer'/><title type='text'>News in pediatric oncology - new treatment for relapsed ALL and more</title><summary type='text'>In the few past months important new discoveries from clinical trials in pediatric hemato-oncology were published. We list some of the most outstanding:1. Mitoxantrone for relapsed ALL - UK Children's Cancer Group reported in Lancet last December that children with relapsed ALL (a disease with poor prognosis, in contrast with primary ALL which is highly curable) benefited from treatment with the </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7219899890950823690'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7219899890950823690'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/04/news-in-pediatric-oncology-new_23.html' title='News in pediatric oncology - new treatment for relapsed ALL and more'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://lh6.ggpht.com/_ltzeFnIlO7Q/TbMb6OMSqPI/AAAAAAAABoU/T6TWwsrAQ-w/s72-c/%5BUNSET%5D.jpg?imgmax=800' height='72' width='72'/></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3589137692478612293</id><published>2011-04-14T21:36:00.000-03:00</published><updated>2011-07-02T11:38:05.896-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='genetics'/><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><title type='text'>The inheritance of alzheimer</title><summary type='text'>People with a maternal history of Alzheimer's disease of late onset are twice as likely to suffer a reduction in gray matter volume in vulnerable areas of the brain, compared to those who  have a father with the disease or those without family history. Using voxel morphometry techniques, the authors of an article published in the journal Neurology, have found different brain regions of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3589137692478612293'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3589137692478612293'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/04/inheritance-of-alzheimer.html' title='The inheritance of alzheimer'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8433706375583344850</id><published>2011-03-26T10:00:00.000-03:00</published><updated>2011-07-02T11:14:54.847-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacological treatment'/><category scheme='http://www.blogger.com/atom/ns#' term='novos tratamentos'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='targeted therapy'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='anticâncer'/><title type='text'>How targeted cancer therapies work: a video from AAAS</title><summary type='text'>Science Magazine has produced a video that is available from its Video Portal. In this video, renowned  medical researchers explain how targeted cancer therapies may develop into better treatments in the future and how molecular knowledge has changed the way we understand and treat cancer.</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8433706375583344850'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8433706375583344850'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/03/how-targeted-cancer-therapies-work.html' title='How targeted cancer therapies work: a video from AAAS'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3464657125233050335</id><published>2011-02-26T23:31:00.002-03:00</published><updated>2011-09-18T12:29:09.609-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='CT scans'/><category scheme='http://www.blogger.com/atom/ns#' term='radiation'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>CT scans and the risk of cancer - hunt the haunt</title><summary type='text'>A recent article published in Science Magazine has discussed recent concerns that CT scans radiation exposure could lead to cancer. The work of biophysicist David Brenner (Columbia University's Center for Radiological Research Director) has sparked controversy in the field. In a 2001 paper, he tried to weight the risks of radiation exposure in CT scans and found that children that received </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3464657125233050335'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3464657125233050335'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/02/ct-scans-and-risk-of-cancer-hunt-haunt.html' title='CT scans and the risk of cancer - hunt the haunt'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1321539804001679215</id><published>2011-02-26T21:52:00.001-03:00</published><updated>2011-03-18T21:07:23.437-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><title type='text'>O fortão da turma não precisa ser o mais burro! - Exercício e capacidade intelectual</title><summary type='text'>Um grupo da Pensilvânia, Illinois, Ohio e Texas (EUA) demonstrou, em um artigo publicado no periódico Proceedings of the National Academy of Sciences of the United States of America, que o treinamento aeróbico melhora a memória e aumenta o tamanho do hipocampo em seres humanos. O estudo, um ensaio clínico com 120 pacientes idosos, mostrou que o exercício aeróbico foi capaz de reverter as </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1321539804001679215'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1321539804001679215'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/02/o-fortao-da-turma-nao-precisa-ser-o.html' title='O fortão da turma não precisa ser o mais burro! - Exercício e capacidade intelectual'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-451674685284650014</id><published>2011-02-04T18:50:00.001-03:00</published><updated>2011-03-18T21:07:23.439-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><title type='text'>Healing with stem cells</title><summary type='text'>The administration of multipotent adult progenitor cells (MAPC) after a spinal cord injury in rodent models prevents shrinkage of neurons, reported a team from Cleveland, Ohio. Inhibition of this process, known as regressive axonal death, reduces inflammation in the region of injury and promotes regeneration of neurons. This study shows that adult stem cells are able to modify certain aspects of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/451674685284650014'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/451674685284650014'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/02/healing-with-stem-cells.html' title='Healing with stem cells'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1750046464926396596</id><published>2011-01-09T18:12:00.001-03:00</published><updated>2011-09-18T12:27:16.203-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='genetics'/><category scheme='http://www.blogger.com/atom/ns#' term='chronic fatigue syndrome'/><category scheme='http://www.blogger.com/atom/ns#' term='fibromialgia'/><category scheme='http://www.blogger.com/atom/ns#' term='antivirais'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Chronic Intrigue(ing) Syndrome</title><summary type='text'>Heat is on for the chronic fatigue syndrome debate. Since a report in Science apparently revealed a break-through link of this misterious disease with XMRV, a retrovirus also linked to cancer, the field has turn into a complete turmoil. Although other research group published results that seemed to back up the first report, a multitude of scientists all over the world has begun to report negative</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1750046464926396596'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1750046464926396596'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/01/chronic-intrigueing-syndrome.html' title='Chronic Intrigue(ing) Syndrome'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3580346949481309809</id><published>2010-12-26T12:35:00.000-03:00</published><updated>2011-03-18T21:07:23.441-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><category scheme='http://www.blogger.com/atom/ns#' term='tumores cerebrais'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><category scheme='http://www.blogger.com/atom/ns#' term='brain tumor'/><title type='text'>Nova descoberta sobre genes que causam tumores cerebrais</title><summary type='text'>Recente artigo na revista Science mostra os resultados de uma pesquisa levada a cabo por cientistas do Genomics Core Facility, Vall d'Hebrón Institute of Oncology, Barcelona,                               Spain. Eles demonstraram que o gene lethal (3) malignant brain tumor (l(3)mbt) da mosca das frutas Drosophila melanogaster, o qual é responsável pelo surgimento de tumores cerebrais nesta </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3580346949481309809'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3580346949481309809'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/12/nova-descoberta-sobre-genes-que-causam.html' title='Nova descoberta sobre genes que causam tumores cerebrais'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8516215010937796534</id><published>2010-11-19T10:51:00.000-03:00</published><updated>2011-01-18T14:03:21.370-03:00</updated><title type='text'>Dança dos Cientistas</title><summary type='text'>Desde 2008 a coluna The Gonzo Scientist da revista Science patrocina um concurso de dança online somente para cientistas, o "Dance your Ph.D.". Em 2010, mais de 30 grupos de pesquisa ao redor do mundo mandaram videos divertidos e impagáveis. Os vídeos viraram sensação no Youtube. Esse é o vídeo do grupo vencedor de 2010.    Carleton University student's team wins annual "Dance Your Ph.D" contest</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8516215010937796534'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8516215010937796534'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/11/danca-dos-cientistas.html' title='Dança dos Cientistas'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-265246425802156271</id><published>2010-11-18T10:41:00.000-03:00</published><updated>2011-03-18T21:31:11.690-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><category scheme='http://www.blogger.com/atom/ns#' term='dor'/><category scheme='http://www.blogger.com/atom/ns#' term='analgésicos'/><title type='text'>Primeiro Prêmio SBED – Janssen-Cilag: Conheça os trabalhos dos 18 finalistas</title><summary type='text'>














Os melhores trabalhos em suas mãos!

Prezado(a) Doutor(a),

Os trabalhos dos 18 finalistas do 1º prêmio SBED - Janssen-Cilag "O controle da dor nas suas mãos" já estão no site da SBED!

A Sociedade Brasileira para o Estudo da Dor publicou os trabalhos científicos dos médicos finalistas do prêmio, incluindo os 6 vencedores, em uma página exclusiva dentro do seu portal.

Acesse agora</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/265246425802156271'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/265246425802156271'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2011/01/primeiro-premio-sbed-janssen-cilag.html' title='Primeiro Prêmio SBED – Janssen-Cilag: Conheça os trabalhos dos 18 finalistas'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-4350116950453491832</id><published>2010-11-06T14:19:00.000-03:00</published><updated>2011-03-18T21:07:23.443-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><title type='text'>Especial Glia</title><summary type='text'>A revista Science publicou seu número especial Glia, com artigos sobre estas importantes células do sistema nervoso central. Principais destaques:Specification and Morphogenesis of Astrocytes, by Marc R. Freeman. Os astócitos, antigamente vistos apenas como coadjuvantes, agora são um dos focos centrais das neurociências. Cientistas tentam desvendar como eles "conversam" entre si e com os </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4350116950453491832'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/4350116950453491832'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/11/especial-glia.html' title='Especial Glia'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7821764035558666032</id><published>2010-10-20T10:51:00.000-03:00</published><updated>2011-01-18T14:08:39.683-03:00</updated><title type='text'>The secret life of neutrophils</title><summary type='text'>Researchers from Canada and Brazil have made live films of the movement of neutrophils into injured sites and studied what signals target these cells to specific locations.Abstract:Neutrophils are recruited from the blood to sites of sterile inflammation, where they contribute to wound healing but may also cause tissue damage. By using spinning disk confocal intravital microscopy, we examined the</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7821764035558666032'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7821764035558666032'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/10/secret-life-of-neutrophils.html' title='The secret life of neutrophils'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-3685837560951211077</id><published>2010-10-17T10:51:00.000-03:00</published><updated>2011-09-18T12:29:09.617-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pediatric tumors'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatrics'/><category scheme='http://www.blogger.com/atom/ns#' term='child'/><category scheme='http://www.blogger.com/atom/ns#' term='pediatria'/><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>Good news for brazillian children with leukemia</title><summary type='text'>Brazillian researchers from FIOCRUZ and INCA have shown that childhood leukemia's mortality is decreasing in a steady state.Abstract:Objective: To analyze trends in childhood leukemia mortality in the state of Rio de Janeiro, Brazil, between 1980 and 2006. Method: Gender-stratified leukemia mortality data for children aged &lt; 15 years from 1980 to 2006 were retrieved from the Brazilian Mortality </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3685837560951211077'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/3685837560951211077'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/10/good-news-for-brazillian-children-with.html' title='Good news for brazillian children with leukemia'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-7091066453498515260</id><published>2010-10-14T10:51:00.000-03:00</published><updated>2011-03-18T21:31:11.693-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><title type='text'>Salbutamol for Multiple Sclerosis</title><summary type='text'>Scientists from Harvard, NIH and Chicago's Northwestern University reported the results of a clinical trial that found albuterol is effective for the treatment of multiple sclerosis patients.Abstract:Background  Interleukin 12 (IL-12), a cytokine that promotes generation of helper T cells subtype 1, is increased in multiple sclerosis. Albuterol sulfate, a β2-adrenergic agonist, reduces IL-12 </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7091066453498515260'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/7091066453498515260'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/10/salbutamol-for-multiple-sclerosis.html' title='Salbutamol for Multiple Sclerosis'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-1670594087932156155</id><published>2010-10-09T10:51:00.000-03:00</published><updated>2011-03-18T21:07:23.447-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='neurology'/><title type='text'>The tau of Alzheimer</title><summary type='text'>Scientists from UCLA and Stanford show tau protein role in the development of Alzheimer's disease.Abstract:Amyloid-β (Aβ) peptides, derived from the amyloid precursor protein, and the microtubule-associated protein tau are key pathogenic factors in Alzheimer’s disease (AD). How exactly they impair cognitive functions is unknown. We assessed the effects of Aβ and tau on axonal transport of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1670594087932156155'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/1670594087932156155'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/10/tau-of-alzheimer.html' title='The tau of Alzheimer'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-2945373866683518072</id><published>2010-09-20T10:51:00.000-03:00</published><updated>2011-03-18T20:51:13.440-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='cancer'/><title type='text'>The sweetness of cancer</title><summary type='text'>Researchers from Harvard and Princenton discovered a new away cancer cells use nutrients to bolster their energy-producing cellular machinery. This break-through finding can help design new anticancer drugs.Abstract:Proliferating cells, including cancer cells, require altered metabolism to efficiently incorporate nutrients such as glucose into biomass. The M2 isoform of pyruvate kinase (PKM2) </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2945373866683518072'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/2945373866683518072'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/09/sweetness-of-cancer.html' title='The sweetness of cancer'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-213038917668029330</id><published>2010-09-08T10:51:00.000-03:00</published><updated>2011-03-18T21:31:11.695-03:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='pharmacology'/><category scheme='http://www.blogger.com/atom/ns#' term='farmacologia'/><title type='text'>Targeting the uprising of malarial resistance</title><summary type='text'>A new class of drugs holds the promise to control multidrug-resistant malaria causing microbes. A report of a joint team of collaborators from USA, Switzerland, Singapore and Thailand.Abstract:Recent reports of increased tolerance to artemisinin derivatives—the most recently adopted class of antimalarials—have prompted a need for new treatments. The spirotetrahydro-β-carbolines, or spiroindolones</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/213038917668029330'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/213038917668029330'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/09/targeting-uprising-of-malarial.html' title='Targeting the uprising of malarial resistance'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry><entry><id>tag:blogger.com,1999:blog-2993346515708552092.post-8346430603319783849</id><published>2010-08-29T10:51:00.000-03:00</published><updated>2011-01-18T14:16:20.337-03:00</updated><title type='text'>Inflammation: telling it by heart</title><summary type='text'>Brazillian scientists review evidence linking cardiovascular diseases and ankylosing spondylitis, a rheumatological condition characterized by chronic pain and inflammation.Abstract:Ankylosing spondylitis (AS) is a systemic inflammatory rheumatic disease characterized primarily by axial joint involvement, sacroiliitis and various extra-articular manifestations. High cardiovascular mortality in AS</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8346430603319783849'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2993346515708552092/posts/default/8346430603319783849'/><link rel='alternate' type='text/html' href='http://pharmak.blogspot.com/2010/08/inflammation-telling-it-by-heart.html' title='Inflammation: telling it by heart'/><author><name>Helder Felix</name><uri>https://profiles.google.com/100842240662296017259</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='32' src='//lh4.googleusercontent.com/-tamCCt7oJu4/AAAAAAAAAAI/AAAAAAAABsE/r1Bkzf2perQ/s512-c/photo.jpg'/></author></entry></feed>
